Overall, merging both subgroups, we validated three of the four genes observed in the full data set when performing the same analysis: TOX and GTSF1 were upregulated in late-stage CTCL, and LTBP4 was upregulated in early-stage CTCL. The gene discussed is TOX; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.